Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
07/2012
07/18/2012CN102584804A Process for preparing olmesartan medoxomil with trityl olmesartan medoxomil deprotection base
07/18/2012CN102584803A Preparation method of high-content quizalofop-P-tefuryl
07/18/2012CN102584802A Preparation method for propiconazole serving as bactericide
07/18/2012CN102584801A One pot method asymmetric synthesis process of HIV reverse transcriptase inhibitor Efavirenz compound
07/18/2012CN102584800A Compound containing framework of chiral indolone and angelica lactone and asymmetric synthesis method
07/18/2012CN102584718A Method for synthesizing quinazoline-4-(3H)-ketone
07/18/2012CN102079747B Olmesartan medoxomil key intermediate, synthesis method thereof and method for synthesizing olmesartan medoxomil from same
07/18/2012CN101466676B Pyridyl amide T-type calcium channel antagonists
07/17/2012US8222430 1-heterodiene derivative and harmful organism control agent
07/17/2012US8222418 Piperidines and related compounds for the treatment of dementia
07/17/2012US8222274 Pyrrole derivative or salt thereof
07/17/2012US8222255 Antifungal agents
07/17/2012CA2700319C Carbonates for use in the preparation of derivatives of dioxan-2-alkyl carbamates
07/17/2012CA2469187C Cis-2,4,5-triphenyl-imidazolines and their use in the treatment of tumors
07/17/2012CA2451028C Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride
07/17/2012CA2334342C Epothilone derivatives and their synthesis and use
07/12/2012WO2012094462A2 Heterocyclic compounds for the inhibition of pask
07/12/2012WO2012093708A1 Novel bicyclic compound or salt thereof
07/12/2012WO2012093688A1 Imidazole compound production method, imidazole compound, imidazole-based compound, organic metal complex, material for organic electroluminescent element, organic electroluminescent element, display device, and lighting device
07/12/2012WO2012093101A1 Indole compounds or analogues thereof useful for the treatment of age-related macular degeneration (amd)
07/12/2012WO2012093100A1 Pyrazol-4-yl carboxamide derivatives as microbiocides
07/12/2012WO2012092827A1 Chemical compounds
07/12/2012US20120178934 N- [2-hydroxycarbamoyl-2- (piperazinyl) ethyl] benzamide compounds, their preparation and their use as tace inhibitors
07/12/2012US20120178764 Novel Compounds
07/12/2012US20120178756 Compounds useful as inhibitors of atr kinase
07/12/2012US20120178741 Sulfonylamino-Derivatives As Novel Inhibitors Of Histone Deacetylase
07/12/2012US20120178622 Aminoquinazoline Compounds for Combating Invertebrate Pests
07/12/2012US20120177712 antimicrobial particle and a process for preparing the same
07/12/2012US20120177570 Trpv1 antagonists including amide substituent and uses thereof
07/12/2012US20120175600 Aromatic amine derivative, and organic electroluminescent element
07/12/2012CA2825089A1 Chemical compounds
07/12/2012CA2824013A1 Novel bicyclic compound or salt thereof
07/12/2012CA2823753A1 Heterocyclic compounds for the inhibition of pask
07/12/2012CA2823665A1 Indole compounds or analogues thereof useful for the treatment of age-related macular degeneration (amd)
07/11/2012EP2474540A1 Gpr119 agonist
07/11/2012EP2474531A2 Matrix metalloproteinase inhibitors
07/11/2012EP2474530A1 Indole derivative and pharmacologically acceptable salt thereof
07/11/2012EP2473505A1 Pyrazinylpyridines useful for the treatment of proliferative diseases
07/11/2012EP2473502A1 Heteroaryl compounds as kinase inhibitors
07/11/2012EP2473501A1 Compounds as tyrosine kinase modulators
07/11/2012EP2473499A1 Bipyridines useful for the treatment of proliferative diseases
07/11/2012EP2473498A1 Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors
07/11/2012EP2473048A1 Pyranyl aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators
07/11/2012EP2473041A1 Modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors
07/11/2012EP1940401B1 Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
07/11/2012EP1856097B1 Pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity
07/11/2012EP1751127B1 Novel cylopenta[b]benzofuran derivatives and the utilization thereof
07/11/2012EP1470121B1 Pyrimidine derivatives as rho-kinase inhibitors
07/11/2012CN1543455B 3-phenoxy-4-pyridazinol derivative and herbicide composition containing the same
07/11/2012CN102575155A Novel organic electroluminescent compounds and organic electroluminescent device using the same
07/11/2012CN102574836A Aminopyrazole derivative
07/11/2012CN102574816A Potent small molecule inhibitors of autophagy, and methods of use thereof
07/11/2012CN102574813A Cyclic azine derivatives, processes for producing these, and organic electroluminescent element containing these as component
07/11/2012CN102574812A New benzimidazole derivatives and their use as fxr agonists
07/11/2012CN102574805A Novel quinoline-hepcidine antagonists
07/11/2012CN102574804A Quinolinyloxyphenylsulfonamides
07/11/2012CN102574790A Aromatic amine derivative, and organic electroluminescent element
07/11/2012CN102574789A Pyrrolidinone carboxamide derivatives as chemerin-R ( CHEMR23 ) modulators
07/11/2012CN102574788A Indole derivatives as crac modulators
07/11/2012CN102564074A Equipment and method for drying triglycidyl isocyanurate
07/11/2012CN102558164A Benzopyrone estrogen receptor (ER) modulator
07/11/2012CN102558161A Process for refining olmesartan medoxomil by adopting mixed solution of acetone and water
07/11/2012CN102558160A 4-substituted p-methyl sulfonamide anilino-quinazoline derivatives and preparation method and application thereof
07/11/2012CN102558159A 4-subsittution m sulfonylurea amide aniline-quinazoline derivate and preparation method and application thereof
07/11/2012CN102558155A 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
07/11/2012CN102558149A Pyrimidine derivative, preparation method thereof, medicinal composition and application thereof
07/11/2012CN102558147A Compound, and preparation method and application thereof
07/11/2012CN102558146A 1-N-substituent-6-pyrazol methylene chinoline-4-ketone-3-formic acid compound, and preparation method and application thereof
07/11/2012CN102558121A Compound for organic optoelectronic device, organic light emitting diode and display device
07/11/2012CN102558067A 1-arylsulfonyl-1H-benzimidazole derivative and preparation method and application thereof
07/11/2012CN102558055A Preparation method of 1-(2- formaldehyde base phenyl) pyrazol
07/11/2012CN102558023A Organic light-emitting device
07/11/2012CN101899040B Preparation process of difenoconazole
07/11/2012CN101353344B Pyrazolyl-substituted heterocycles and their use as phytosanitary products
07/11/2012CN101139345B Polymorphic forms of 1-'4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
07/10/2012US8217067 Antiinflammatory agents, antidepressants, analgesics, purinergic receptor antagonists; neurodegenerative diseases, spinal cord injuries; 1-(2,3-dichlorophenyl)-N-[(2-methylphenyl)methyl]-1H-tetraazol-5-amine
07/10/2012US8217044 Spiroindolinone pyrrolidines
07/10/2012CA2658334C Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
07/10/2012CA2583087C Chroman derivatives
07/10/2012CA2564062C Indole derivative having piperidine ring
07/10/2012CA2553269C Quinoline derivatives and use thereof as mycobacterial inhibitors
07/10/2012CA2551171C Modulators of peripheral 5-ht receptors
07/10/2012CA2545942C Aryl imidazoles and their use as anti-cancer agents
07/10/2012CA2543820C Methods for synthesizing quinolinone compounds
07/10/2012CA2526430C Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
07/10/2012CA2513463C Gyrase inhibitors and uses thereof
07/10/2012CA2507381C Process for preparing quinazoline rho-kinase inhibitors and intermediates thereof
07/10/2012CA2481369C Inhibitors of serine proteases, particularly hepatitis c virus ns3 - ns4 protease
07/10/2012CA2444704C Synthesis and evaluation of phthalimide mimics as anti-angiogenic agents
07/05/2012WO2012090179A2 Isoquinoline derivatives as cannabinoid receptor modulators
07/05/2012WO2012090177A2 Cannabinoid receptor modulators
07/05/2012WO2012089828A2 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
07/05/2012WO2012089601A1 New biaryl amide derivatives
07/05/2012WO2012089137A1 Arylurea compound, intermediate and use thereof
07/05/2012WO2012064744A3 N- sulfonylated tetrahydroquinolines and related bicyclic compounds inhibition of rory activity and the treatment of diseases
07/05/2012US20120172603 Polymers bearing pendant pentafluorophenyl ester groups, and methods of synthesis and functionalization thereof
07/05/2012US20120172602 Polymers bearing pendant pentafluorophenyl ester groups, and methods of synthesis and functionalization thereof
07/05/2012US20120172399 Compounds as hypoxia mimetics, and composiitons and uses thereof
07/05/2012US20120172376 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
07/05/2012US20120172374 Novel tubulin inhibitors and methods of using the same
1 ... 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 ... 694